Cover Image
Market Research Report

Oncology Drugs Global Market Report 2020-30: Covid 19 Impact and Recovery

Published by The Business Research Company Product code 937127
Published Content info
Delivery time: 2-3 business days
Price
Back to Top
Oncology Drugs Global Market Report 2020-30: Covid 19 Impact and Recovery
Published: May 19, 2020 Content info:
Description

‘Oncology Drugs Global Market Report 2020-30: Covid 19 Impact and Recovery ’ from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global oncology drugs market as it emerges from the Covid 19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the oncology drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Oncology Drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider oncology drugs market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the Covid 19 virus and forecasting its recovery.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The oncology drugs market section of the report gives context. It compares the oncology drugs market with other segments of the pharmaceutical drugs market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, oncology drugs indicators comparison.

Scope

Markets Covered:

1) By Type: Lung Cancer; Pancreatic Cancer; Breast Cancer; Prostate Cancer; Ovarian Cancer; Colorectal Cancer; Gastric Cancer; Kidney Cancer; Brain Tumor; Thyroid Cancer; Skin Cancer; Bladder Cancer; Cervical Cancer; Blood Cancer; Others (Kaposi Sarcoma, AIDS-Related Lymphoma, Anal Cancer, Bone Cancer, Retinoblastoma, Testicular Cancer, Hepatocellular (Liver) Cancer, Mouth Cancer, Neuroblastoma)

2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Others

3) By Route Of Administration: Oral; Parenteral; Others

4) By Drug Classification: Branded Drugs; Generic Drugs

5) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs

Companies Mentioned: F. Hoffmann-La Roche Ltd; Novartis AG; Gilead Sciences Inc; Bayer AG; Takeda Pharmaceticals

Metrics Covered: Number of Enterprises; Number of Employees

Countries: Argentina; Australia; Austria; Belgium; Brazil; Canada; Chile; China; Colombia; Czech Republic; Denmark; Egypt; Finland; France; Germany; Hong Kong; India; Indonesia; Ireland; Israel; Italy; Japan; Malaysia; Mexico; Netherlands; New Zealand; Nigeria; Norway; Peru; Philippines; Poland; Portugal; Romania; Russia; Saudi Arabia; Singapore; South Africa; South Korea; Spain; Sweden; Switzerland; Thailand; Turkey; UAE; UK; USA; Venezuela; Vietnam

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, oncology drugs indicators comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

Table of Contents

1. Executive Summary

2. Report Structure

3. Oncology Drugs Market Characteristics

  • 3.1. Market Definition
  • 3.2. Key Segmentations

4. Oncology Drugs Market Product Analysis

  • 4.1. Leading Products/ Services
  • 4.2. Key Features and Differentiators
  • 4.3. Development Products

5. Oncology Drugs Market Supply Chain

  • 5.1. Supply Chain
  • 5.2. Distribution
  • 5.3. End Customers

6. Oncology Drugs Market Customer Information

  • 6.1. Customer Preferences
  • 6.2. End Use Market Size and Growth

7. Oncology Drugs Market Trends And Strategies

8. Oncology Drugs Market Size And Growth

  • 8.1. Market Size
  • 8.2. Historic Market Growth, Value ($ Billion)
    • 8.2.1. Drivers Of The Market
    • 8.2.2. Restraints On The Market
  • 8.3. Forecast Market Growth, Value ($ Billion)
    • 8.3.1. Drivers Of The Market
    • 8.3.2. Restraints On The Market

9. Oncology Drugs Market Regional Analysis

  • 9.1. Global Oncology Drugs Market, 2019, By Region, Value ($ Billion)
  • 9.2. Global Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region
  • 9.3. Global Oncology Drugs Market, Growth And Market Share Comparison, By Region

10. Oncology Drugs Market Segmentation

  • 10.1. Global Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Lung Cancer

Pancreatic Cancer

Breast Cancer

Prostate Cancer

Ovarian Cancer

Colorectal Cancer

Gastric Cancer

Kidney Cancer

Brain Tumor

Thyroid Cancer

Skin Cancer

Bladder Cancer

Cervical Cancer

Blood Cancer

Others (Kaposi Sarcoma, AIDS-Related Lymphoma, Anal Cancer, Bone Cancer, Retinoblastoma, Testicular Cancer, Hepatocellular (Liver) Cancer, Mouth Cancer, Neuroblastoma)

  • 10.2. Global Oncology Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Hospital Pharmacies

Retail Pharmacies/ Drug Stores

Others

  • 10.3. Global Oncology Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Oral

Parenteral

Others

  • 10.4. Global Oncology Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Branded Drugs

Generic Drugs

  • 10.5. Global Oncology Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Prescription-Based Drugs

Over-The-Counter Drugs

11. Oncology Drugs Market Metrics

  • 11.1. Oncology Drugs Market Size, Percentage Of GDP, 2015-2023, Global
  • 11.2. Per Capita Average Oncology Drugs Market Expenditure, 2015-2023, Global

12. Asia-Pacific Oncology Drugs Market

  • 12.1. Asia-Pacific Oncology Drugs Market Overview
  • 12.2. Asia-Pacific, Oncology Drugs Market, 2019, By Country, Value ($ Billion)
  • 12.3. Asia-Pacific, Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 12.4. Asia-Pacific, Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 12.5. Asia-Pacific, Oncology Drugs Market Metrics
    • 12.5.1. Per Capita Average Oncology Drugs Expenditure, 2015-2023, Asia-Pacific Countries
    • 12.5.2. Cancer Prevalence Rate, Oncology Drugs Market, Oncology Drugs Market/Cancer Prevalence Rate, 2019, Asia-Pacific Countries
  • 12.6. Asia-Pacific Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 12.7. Asia-Pacific Oncology Drugs Market: Country Analysis
    • 12.7.1. China Oncology Drugs Market
      • 12.7.1.1. China Oncology Drugs Market Overview
      • 12.7.1.2. China Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.1.3. China Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.2. Australia Oncology Drugs Market
      • 12.7.2.1. Australia Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.2.2. Australia Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.3. Hong Kong Oncology Drugs Market
      • 12.7.3.1. Hong Kong Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.4. India Oncology Drugs Market
      • 12.7.4.1. India Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.4.2. India Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.5. Indonesia Oncology Drugs Market
      • 12.7.5.1. Indonesia Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.5.2. Indonesia Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.6. Japan Oncology Drugs Market
      • 12.7.6.1. Japan Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.6.2. Japan Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.7. Malaysia Oncology Drugs Market
      • 12.7.7.1. Malaysia Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.8. New Zealand Oncology Drugs Market
      • 12.7.8.1. New Zealand Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.9. Philippines Oncology Drugs Market
      • 12.7.9.1. Philippines Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.10. Singapore Oncology Drugs Market
      • 12.7.10.1. Singapore Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.11. South Korea Oncology Drugs Market
      • 12.7.11.1. South Korea Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.11.2. South Korea Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.12. Thailand Oncology Drugs Market
      • 12.7.12.1. Thailand Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.13. Vietnam Oncology Drugs Market
      • 12.7.13.1. Vietnam Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

13. Western Europe Oncology Drugs Market

  • 13.1. Western Europe Oncology Drugs Market Overview
  • 13.2. Western Europe, Oncology Drugs Market, 2019, By Country, Value ($ Billion)
  • 13.3. Western Europe, Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 13.4. Western Europe, Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 13.5. Western Europe, Oncology Drugs Market Metrics
    • 13.5.1. Per Capita Average Oncology Drugs Expenditure, 2015-2023, Western Europe Countries
    • 13.5.2. Cancer Prevalence Rate, Oncology Drugs Market, Oncology Drugs Market/Cancer Prevalence Rate, 2019, Western Europe Countries
  • 13.6. Western Europe Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 13.7. Western Europe Oncology Drugs Market: Country Analysis
    • 13.7.1. Austria Oncology Drugs Market
      • 13.7.1.1. Austria Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.2. Belgium Oncology Drugs Market
      • 13.7.2.1. Belgium Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.3. Denmark Oncology Drugs Market
      • 13.7.3.1. Denmark Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.4. Finland Oncology Drugs Market
      • 13.7.4.1. Finland Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.5. France Oncology Drugs Market
      • 13.7.5.1. France Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 13.7.5.2. France Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.6. Germany Oncology Drugs Market
      • 13.7.6.1. Germany Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 13.7.6.2. Germany Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.7. Ireland Oncology Drugs Market
      • 13.7.7.1. Ireland Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.8. Italy Oncology Drugs Market
      • 13.7.8.1. Italy Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.9. Netherlands Oncology Drugs Market
      • 13.7.9.1. Netherlands Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.10. Norway Oncology Drugs Market
      • 13.7.10.1. Norway Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.11. Portugal Oncology Drugs Market
      • 13.7.11.1. Portugal Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.12. Spain Oncology Drugs Market
      • 13.7.12.1. Spain Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.13. Sweden Oncology Drugs Market
      • 13.7.13.1. Sweden Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.14. Switzerland Oncology Drugs Market
      • 13.7.14.1. Switzerland Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.15. UK Oncology Drugs Market
      • 13.7.15.1. UK Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 13.7.15.2. UK Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

14. Eastern Europe Oncology Drugs Market

  • 14.1. Eastern Europe Oncology Drugs Market Overview
  • 14.2. Eastern Europe, Oncology Drugs Market, 2019, By Country, Value ($ Billion)
  • 14.3. Eastern Europe, Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 14.4. Eastern Europe, Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 14.5. Eastern Europe, Oncology Drugs Market Metrics
    • 14.5.1. Per Capita Average Oncology Drugs Expenditure, 2015-2023, Eastern Europe Countries
    • 14.5.2. Cancer Prevalence Rate, Oncology Drugs Market, Oncology Drugs Market/Cancer Prevalence Rate, 2019, Eastern Europe Countries
  • 14.6. Eastern Europe Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 14.7. Eastern Europe Oncology Drugs Market: Country Analysis
    • 14.7.1. Czech Republic Oncology Drugs Market,
      • 14.7.1.1. Czech Republic Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 14.7.2. Poland Oncology Drugs Market
      • 14.7.2.1. Poland Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 14.7.3. Romania Oncology Drugs Market
      • 14.7.3.1. Romania Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 14.7.4. Russia Oncology Drugs Market
      • 14.7.4.1. Russia Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 14.7.4.2. Russia Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

15. North America Oncology Drugs Market

  • 15.1. North America Oncology Drugs Market Overview
  • 15.2. North America, Oncology Drugs Market, 2019, By Country, Value ($ Billion)
  • 15.3. North America, Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 15.4. North America, Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 15.5. North America, Oncology Drugs Market Metrics
    • 15.5.1. Per Capita Average Oncology Drugs Expenditure, 2015-2023, North America Countries
    • 15.5.2. Cancer Prevalence Rate, Oncology Drugs Market, Oncology Drugs Market/Cancer Prevalence Rate, 2019, North America Countries
  • 15.6. North America Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 15.7. North America Oncology Drugs Market: Country Analysis
    • 15.7.1. Canada Oncology Drugs Market
      • 15.7.1.1. Canada Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 15.7.2. Mexico Oncology Drugs Market
      • 15.7.2.1. Mexico Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 15.7.3. USA Oncology Drugs Market
      • 15.7.3.1. USA Oncology Drugs Market Overview
      • 15.7.3.2. USA Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 15.7.3.3. USA Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

16. South America Oncology Drugs Market

  • 16.1. South America Oncology Drugs Market Overview
  • 16.2. South America, Oncology Drugs Market, 2019, By Country, Value ($ Billion)
  • 16.3. South America, Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 16.4. South America, Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 16.5. South America, Oncology Drugs Market Metrics
    • 16.5.1. Per Capita Average Oncology Drugs Expenditure, 2015-2023, South America Countries
    • 16.5.2. Cancer Prevalence Rate, Oncology Drugs Market, Oncology Drugs Market/Cancer Prevalence Rate, 2019, South America Countries
  • 16.6. South America Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 16.7. South America Oncology Drugs Market: Country Analysis
    • 16.7.1. Argentina Oncology Drugs Market
      • 16.7.1.1. Argentina Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 16.7.2. Brazil Oncology Drugs Market
      • 16.7.1.1. Brazil Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 16.7.2.2. Brazil Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 16.7.3. Chile Oncology Drugs Market
      • 16.7.3.1. Chile Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 16.7.4. Colombia Oncology Drugs Market
      • 16.7.4.1. Colombia Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 16.7.5. Peru Oncology Drugs Market
      • 16.7.5.1. Peru Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 16.7.6. Venezuela Oncology Drugs Market
      • 16.7.6.1. Venezuela Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

17. Middle East Oncology Drugs Market

  • 17.1. Middle East Oncology Drugs Market Overview
  • 17.2. Middle East, Oncology Drugs Market, 2019, By Country, Value ($ Billion)
  • 17.3. Middle East, Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 17.4. Middle East, Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 17.5. Middle East, Oncology Drugs Market Metrics
    • 17.5.1. Per Capita Average Oncology Drugs Expenditure, 2015-2023, Middle East Countries
    • 17.5.2. Cancer Prevalence Rate, Oncology Drugs Market, Oncology Drugs Market/Cancer Prevalence Rate, 2019, Middle East Countries
  • 17.6. Middle East Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 17.7. Middle East Oncology Drugs Market: Country Analysis
    • 17.7.1. Saudi Arabia Oncology Drugs Market
      • 17.7.1.1. Saudi Arabia Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 17.7.2. Israel Oncology Drugs Market
      • 17.7.2.1. Israel Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 17.7.3. Turkey Oncology Drugs Market
      • 17.7.3.1. Turkey Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 17.7.4. UAE Oncology Drugs Market
      • 17.7.4.1. UAE Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

18. Africa Oncology Drugs Market

  • 18.1. Africa Oncology Drugs Market Overview
  • 18.2. Africa, Oncology Drugs Market, 2019, By Country, Value ($ Billion)
  • 18.3. Africa, Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 18.4. Africa, Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 18.5. Africa, Oncology Drugs Market Metrics
    • 18.5.1. Per Capita Average Oncology Drugs Expenditure, 2015-2023, Africa Countries
    • 18.5.2. Cancer Prevalence Rate, Oncology Drugs Market, Oncology Drugs Market/Cancer Prevalence Rate, 2019, Africa Countries
  • 18.6. Africa Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 18.7. Africa Oncology Drugs Market: Country Analysis
    • 18.7.1. Egypt Oncology Drugs Market
      • 18.7.1.1. Egypt Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 18.7.2. Nigeria Oncology Drugs Market
      • 18.7.2.1. Nigeria Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 18.7.3. South Africa Oncology Drugs Market
      • 18.7.3.1. South Africa Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

19. Oncology Drugs Market Competitive Landscape

  • 19.1. Competitive Market Overview
  • 19.2. Market Shares
  • 19.3. Company Profiles
    • 19.3.1. F. Hoffmann-La Roche Ltd
      • 19.3.1.1. Company Overview
      • 19.3.1.2. Products And Services
      • 19.3.1.3. Strategy
      • 19.3.1.4. Financial Performance
    • 19.3.2. Novartis AG
      • 19.3.2.1. Company Overview
      • 19.3.2.2. Products And Services
      • 19.3.2.3. Strategy
      • 19.3.2.4. Financial Performance
    • 19.3.3. Gilead Sciences Inc
      • 19.3.3.1. Company Overview
      • 19.3.3.2. Products And Services
      • 19.3.3.3. Strategy
      • 19.3.3.4. Financial Performance
    • 19.3.4. Bayer AG
      • 19.3.4.1. Company Overview
      • 19.3.4.2. Products And Services
      • 19.3.4.3. Strategy
      • 19.3.4.4. Financial Performance
    • 19.3.5. Takeda Pharmaceticals
      • 19.3.5.1. Company Overview
      • 19.3.5.2. Products And Services
      • 19.3.5.3. Strategy
      • 19.3.5.4. Financial Performance

20. Key Mergers And Acquisitions In The Oncology Drugs Market

21. Market Background: Pharmaceutical Drugs Market

  • 21.1. Pharmaceutical Drugs Market Characteristics
  • 21.2. Pharmaceutical Drugs Market Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F Growth, By Segment, Value ($ Billion), Global
  • 21.3. Global Pharmaceutical Drugs Market, 2019, By Region, Value ($ Billion)
  • 21.4. Global Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region
  • 21.5. Global Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Segmentation By Type, Value ($ Billion)

22. Recommendations

  • 22.1. Global Oncology Drugs Market In 2023- Growth Countries
  • 22.2. Global Oncology Drugs Market In 2023- Growth Segments
  • 22.3. Global Oncology Drugs Market In 2023- Growth Strategies

23. Appendix

  • 23.1. NAICS Definitions Of Industry Covered In This Report
  • 23.2. Abbreviations
  • 23.3. Currencies
  • 23.4. Research Inquiries
  • 23.5. The Business Research Company

24. Copyright And Disclaimer

Back to Top